In addition to tumor cells, survivin has also been shown in autoimmune diseases such as rheumatoid arthritis and multiple sclerosis, where its cytokine-dependent expression correlates with decreased apoptosis and inflammation. Here, BIRC5 is linked to rheumatoid arthritis.